Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1988 1
1989 1
1996 2
2000 1
2001 1
2002 1
2004 2
2005 4
2006 3
2007 5
2008 5
2009 4
2010 5
2011 5
2012 9
2013 6
2014 5
2015 5
2016 13
2017 11
2018 3
2019 6
2020 3
2021 8
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22097923

101 results

Results by year

Filters applied: . Clear all
Page 1
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. Romero R, et al. J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23. doi: 10.1080/14767050701830480. J Matern Fetal Neonatal Med. 2008. PMID: 18175241 Free PMC article.
Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network. Powers RW, et al. PLoS One. 2010 Oct 11;5(10):e13263. doi: 10.1371/journal.pone.0013263. PLoS One. 2010. PMID: 20948996 Free PMC article.
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE. Kim MY, et al. Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14. doi: 10.1016/j.ajog.2015.09.066. Epub 2015 Sep 29. Am J Obstet Gynecol. 2016. PMID: 26432463 Free PMC article.
An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G, Yildizhan R. Cim N, et al. J Matern Fetal Neonatal Med. 2017 Jul;30(13):1602-1607. doi: 10.1080/14767058.2016.1219986. Epub 2016 Sep 23. J Matern Fetal Neonatal Med. 2017. PMID: 27658884
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS. Chaiworapongsa T, et al. Am J Obstet Gynecol. 2013 Apr;208(4):287.e1-287.e15. doi: 10.1016/j.ajog.2013.01.016. Epub 2013 Jan 17. Am J Obstet Gynecol. 2013. PMID: 23333542 Free PMC article.
101 results